[HTML][HTML] COVID-19: pathophysiology, diagnosis, complications and investigational therapeutics
SA Azer - New Microbes and New Infections, 2020 - Elsevier
Abstract The novel coronavirus (COVID-19) outbreak started early in December 2019 in the
Hubei province and its capital Wuhan of the People's Republic of China and caused a …
Hubei province and its capital Wuhan of the People's Republic of China and caused a …
An updated insight into the molecular pathogenesis, secondary complications and potential therapeutics of COVID-19 pandemic
Abstract Coronavirus disease 2019 (COVID-19) is an unprecedented disease caused by
highly pathogenic SARS-CoV-2 and characterized by extreme respiratory deterrence …
highly pathogenic SARS-CoV-2 and characterized by extreme respiratory deterrence …
SARS‐CoV‐2: Mechanism of infection and emerging technologies for future prospects
S Li, S Li, C Disoma, R Zheng, M Zhou… - Reviews in Medical …, 2021 - Wiley Online Library
The novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has
spread globally to over 200 countries with more than 23 million confirmed cases and at least …
spread globally to over 200 countries with more than 23 million confirmed cases and at least …
COVID-19: immunopathogenesis and Immunotherapeutics
L Yang, S Liu, J Liu, Z Zhang, X Wan… - Signal transduction and …, 2020 - nature.com
The recent novel coronavirus disease (COVID-19) outbreak, caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), is seeing a rapid increase in infected …
respiratory syndrome coronavirus 2 (SARS-CoV-2), is seeing a rapid increase in infected …
COVID-19: a global challenge with old history, epidemiology and progress so far
Humans have witnessed three deadly pandemics so far in the twenty-first century which are
associated with novel coronaviruses: SARS, Middle East respiratory syndrome (MERS), and …
associated with novel coronaviruses: SARS, Middle East respiratory syndrome (MERS), and …
Understanding the epidemiology, pathophysiology, diagnosis and management of SARS-CoV-2
The emergence of coronavirus disease 2019 (COVID-19) in December 2019 has resulted in
over 20 million cases and 741,808 deaths globally, affecting more than 200 countries …
over 20 million cases and 741,808 deaths globally, affecting more than 200 countries …
Pathophysiology of COVID-19: mechanisms underlying disease severity and progression
MK Bohn, A Hall, L Sepiashvili, B Jung… - …, 2020 - journals.physiology.org
The global epidemiology of coronavirus disease 2019 (COVID-19) suggests a wide
spectrum of clinical severity, ranging from asymptomatic to fatal. Although the clinical and …
spectrum of clinical severity, ranging from asymptomatic to fatal. Although the clinical and …
The interplay between inflammatory pathways and COVID-19: A critical review on pathogenesis and therapeutic options
S Choudhary, K Sharma, O Silakari - Microbial pathogenesis, 2021 - Elsevier
Abstract COVID-19, caused by SARS-CoV-2, emerged as the deadliest outbreak that has
now become a serious health issue to mankind. Activation of inflammatory signaling …
now become a serious health issue to mankind. Activation of inflammatory signaling …
COVID‐19: immunopathology, pathophysiological mechanisms, and treatment options
LE van Eijk, M Binkhorst, AR Bourgonje… - The Journal of …, 2021 - Wiley Online Library
Abstract Coronavirus disease 2019 (COVID‐19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS‐CoV‐2), continues to spread globally despite the worldwide …
syndrome coronavirus 2 (SARS‐CoV‐2), continues to spread globally despite the worldwide …